Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
-
Forxiga approved in the EU for heart failure
-
Year-to-date and Q3 2020 results
-
Atacand to be divested to Cheplapharm in more than 70 countries
-
Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma in PONENTE Phase IIIb trial
-
Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer
-
Forxiga cardiovascular outcomes benefit approved in China
-
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
-
Farxiga DAPA-CKD Phase III trial reduced worsening of kidney function, risk of cardiovascular or renal death in patients with chronic kidney disease, irrespective of underlying cause
-
AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined
Latest articles and press releases
All of our latest press releases and articles are available to explore
